Search Results - "Teresk, Martin"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Thermodynamic and Structural Effects of Conformational Constraints in Protein−Ligand Interactions. Entropic Paradoxy Associated with Ligand Preorganization by DeLorbe, John E, Clements, John H, Teresk, Martin G, Benfield, Aaron P, Plake, Hilary R, Millspaugh, Laura E, Martin, Stephen F

    Published in Journal of the American Chemical Society (25-11-2009)
    “…Succinate- and cyclopropane-derived phosphotyrosine (pY) replacements were incorporated into a series of Grb2 SH2 binding ligands wherein the pY+1 residue was…”
    Get full text
    Journal Article
  2. 2

    Deficiencies in Traditional Oral Dosage Forms and the Emergence of Controlled-Release Powder Manufacturing by Teresk, Martin G., Berkland, Cory J., Dormer, Nathan H.

    Published in KONA Powder and Particle Journal (2017)
    “…The importance of providing safe and effective delayed- and extended-release oral formulations that can replace products requiring multiple administrations has…”
    Get full text
    Journal Article
  3. 3

    Ligand Preorganization May Be Accompanied by Entropic Penalties in Protein-Ligand Interactions by Benfield, Aaron P., Teresk, Martin G., Plake, Hilary R., DeLorbe, John E., Millspaugh, Laura E., Martin, Stephen F.

    Published in Angewandte Chemie International Edition (20-10-2006)
    “…Fact or fiction? It is generally assumed that preorganization of a flexible ligand in the 3D shape it adopts when bound to a macromolecular receptor will…”
    Get full text
    Journal Article
  4. 4

    Evaluation of solution oxygenation requirements for azonitrile-based oxidative forced degradation studies of pharmaceutical compounds by Nelson, Eric D, Harmon, Paul A, Szymanik, Renee C, Teresk, Martin G, Li, Li, Seburg, Randal A, Reed, Robert A

    Published in Journal of pharmaceutical sciences (01-07-2006)
    “…AIBN and ACVA oxidative forced degradation models are examined for two drug molecules whose predominant oxidation chemistries arise from different reaction…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Abstract B085: Preclinical pharmacokinetic/pharmacodynamic (PK/PD) relationship demonstrated for BVD-723, a potent and selective phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor by Knoerzer, Deborah, Teresk, Martin, Krutzik, Peter, O’Donnell, Erika, DeCrescenzo, Gary, Welsch, Dean, Emery, Caroline

    Published in Molecular cancer therapeutics (01-01-2018)
    “…Abstract The phosphoinositide 3-kinase (PI3K) family of enzymes play a pivotal role in controlling vital cellular functions, including proliferation, motility,…”
    Get full text
    Journal Article
  7. 7

    Abstract 2693: Combining ulixertinib (ERK1/2 Inhibitor) with EGFR and BRAF inhibition yields significant efficacy in preclinical BRAF V600E mutant colorectal cancer models by Knoerzer, Deborah, Reddy, Anupama, Box, Jessica A., Groover, Anna, Kreider, Brent, Teresk, Martin, Emery, Caroline M.

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract The BRAFV600E mutation occurs in approximately 7% of colorectal cancer (CRC). BRAF plus EGFR inhibition (encorafenib with cetuximab) is an FDA…”
    Get full text
    Journal Article
  8. 8

    Abstract 2692: The combination of ulixertinib (ERK1/2 Inhibitor) and KRASG12C inhibition demonstrates significant efficacy in preclinical models by Knoerzer, Deborah, Reddy, Anupama, Box, Jessica A., Groover, Anna, Kreider, Brent, Teresk, Martin, Emery, Caroline M.

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Ulixertinib (BVD-523) is a first-in-class and best-in-class small molecule inhibitor of ERK1/2 currently being investigated in several oncology…”
    Get full text
    Journal Article
  9. 9

    Design, synthesis & thermodynamic evaluation of conformationally-constrained pseudopeptides and synthetic approaches to sieboldine A by Teresk, Martin Gerald

    Published 01-01-2008
    “…A series of conformationally constrained and flexible pseudopeptides were prepared and their thermodynamic parameters on binding to the Grb2 SH2 domain were…”
    Get full text
    Dissertation
  10. 10

    Ligand Preorganization May Be Accompanied by Entropic Penalties in Protein-Ligand Interactions by Benfield, Aaron P., Teresk, Martin G., Plake, Hilary R., DeLorbe, John E., Millspaugh, Laura E., Martin, Stephen F.

    Published in Angewandte Chemie (20-10-2006)
    “…Fakt oder Fiktion? Es wird allgemein angenommen, dass die Präorganisation eines flexiblen Liganden zu der dreidimensionalen Form, die er bei der Bindung an…”
    Get full text
    Journal Article
  11. 11